v3.26.1
Stockholders' Equity and Share-Based Compensation (Tables)
12 Months Ended
May 02, 2026
Equity [Abstract]  
Schedule of Nonvested Restricted Stock and Restricted Stock Units Activity
A summary of non-vested restricted stock and RSUs for fiscal years 2026, 2025, and 2024 is as follows:
Year Ended
May 2, 2026April 26, 2025April 27, 2024
Number of Nonvested Shares Weighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Outstanding at beginning of year600 $9.62 486 $5.95 617 $4.11 
Granted251 19.92 318 13.19 159 9.85 
Vested(253)8.88 (189)6.45 (280)3.92 
Forfeited(24)14.21 (15)6.71 (10)4.77 
Outstanding at end of year574 $13.96 600 $9.62 486 $5.95 
Share-based Payment Arrangement, Option, Activity A summary of stock option activity under our 2020 Plan and 2025 Plan during the fiscal year ended May 2, 2026 is as follows:
Stock Options Weighted Average Exercise Price
Per Share
Weighted Average Remaining
Contractual Life (Years)
Aggregate Intrinsic Value
Outstanding as of April 26, 2025
901 $5.78 5.41$6,107 
Granted— — — — 
Cancelled or forfeited(4)8.51 — — 
Exercised(290)6.19 — 4,247 
Outstanding as of May 2, 2026
607 $5.57 4.85$8,573 
   
Shares vested and expected to vest603 $5.56 4.83$8,518 
Exercisable as of May 2, 2026
419 $5.81 4.16$5,827 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the weighted-average fair value of options granted and the related assumptions used in the Black-Scholes model. No stock options were granted during fiscal 2026; therefore, no Black‑Scholes assumptions were applicable.
Year Ended
April 26, 2025April 27, 2024
Fair value of options granted$5.98 $4.92 
Risk-free interest rate3.58 %4.37 %
Expected volatility49.14 %46.28 %
Expected life of option (in years)6.836.90
Schedule of Share-based Compensation Expense
The following table presents a summary of the share-based compensation expense by equity type as follows:
Year Ended
May 2, 2026April 26, 2025April 27, 2024
Stock options$550 $910 $420 
Restricted stock and stock units4,029 1,591 1,177 
Employee stock purchase plans515 443 493 
$5,094 $2,944 $2,090 
A summary of the share-based compensation expense by classification in the Consolidated Statements of Operations for stock options, restricted stock, RSUs, and shares of Common Stock issued under the ESPP for fiscal years 2026, 2025, and 2024 is as follows:
Year Ended
May 2, 2026April 26, 2025April 27, 2024
Cost of sales$968 $613 $452 
Selling778 460 437 
General and administrative2,920 1,577 745 
Product design and development428 294 456 
$5,094 $2,944 $2,090